cro.directory
← Compare landing

Biomere vs PharmaLegacy Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biomere/pharmalegacy

CategoryBiomerePharmaLegacy Laboratories
Listed sitecrocro
SummaryBoston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates, with AAALAC accreditation and extensive vivarium capacity.Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.
Services
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Safety Pharmacology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Ophthalmology
  • Neurology
  • Metabolic
  • Oncology
  • Oncology
  • Immunology
  • Rare Disease
Locations
  • Headquarters, Worcester, MA, United States
  • West Coast Facility, Richmond, CA, United States
  • Headquarters
Certifications
  • AAALAC · Identifier: AAALAC accredited
  • OLAW · Identifier: OLAW Assured
  • DEA · Identifier: DEA Licensed
  • USDA · Identifier: USDA Registered
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.